TCR2 Therapeutics  logo
TCR2 Therapeutics TCRR
$ 1.48 0.0%

Quarterly report 2023-Q1
added 05-11-2023

report update icon

TCR2 Therapeutics EBITDA per Share 2011-2024 | TCRR

Annual EBITDA per Share TCR2 Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-3.89 -2.55 -2.21 -2.39 - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.21 -3.89 -2.76

Quarterly EBITDA per Share TCR2 Therapeutics

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-1.04 - -0.75 -0.79 -0.74 - -0.64 -0.6 -0.57 -0.56 -0.53 -0.67 -0.66 -0.57 -0.6 -0.5 -0.86 -12 -10.3 -10.7 -7.87 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-0.5 -12 -2.68